THE RELATIONSHIP BETWEEN THE EXPRESSION OF NF-κB p65, NF-κB p50 GENES IN TUMOR TISSUE AND SOME TUMOR CHARACTERISTICS IN HBsAg-POSITIVE HEPATOCELLULAR CARCINOMA PATIENTS
Main Article Content
Abstract
Objective: To investigate the expression levels of NF-κB p50 and NF-κB p65 genes in tumor tissues and their association with clinicopathological characteristics in HBsAg-positive Hepatocellular carcinoma (HCC) patients. Subjects and methods: A cross-sectional descriptive study was conducted on 69 patients who underwent hepatectomy for HCC from July 2022 to July 2024. The expression of NF-κB p50 and NF-κB p65 in paired tumor and adjacent non-tumorous tissues was quantified by RT-qPCR. Results: The expression of NF-κB p65, p50 genes had no statistically significant difference in cancer tissue samples compared to adjacent tumor tissue samples (Median (quartiles) were: 1,43 ((-5,18) – 4,73) compared (-0,08) ((-4,38) – 4,02); p = 0,85); and (-4,87) ((-9,41) – (-0,93)) compared (-2,38) ((-8,17) – 4,11); p = 0,07, respectively; p < 0,0001). There was no correlation between the relative expression levels of NF- κB p65, NF- κB p50 genes in cancer tissue and some characteristics of the tumor (size, number, portal vein thrombosis) and pathology (structure, vascular invasion in the tumor, cirrhosis). Conclusion: NF-κB p50, NF-κB p65 genes weren’t increased in tumor tissue compared to adjacent tumor tissue. There was no correlation between the relative expression levels of NF-κB p50 and NF-κB p65 genes in cancer tissue and some features of the tumor and pathology.
Article Details
Keywords
NF-κB p65, NF-κB p50, hepatocellular carcinoma, HBsAg ( ).
References
2. Pham T., Bui L., Kim G., et al. (2019). Cancers in Vietnam-Burden and Control Efforts: A Narrative Scoping Review. Cancer Control, 26(1): 1073274819863802.
3. Yeh S.H., Li C.L., Lin Y.Y., et al. (2023). Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC. Cell Mol Gastroenterol Hepatol, 15(4): 921-9.
4. Xiao C., Ghosh S. (2005). NF-kappaB, an evolutionarily conserved mediator of immune and inflammatory responses. Adv Exp Med Biol, 560: 41-5.
5. Copetti T., Bertoli C., Dalla E., et al. (2009). p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol, 29(10): 2594-608.
6. Yu Y., Wan Y., Huang C. (2009). The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target. Curr Cancer Drug Targets, 9(4): 566-71.
7. Silva G.J.A., Galicia M.M., Sandoval R.A., et al. (2021). Hepatocarcinogenesis Prevention by Pirfenidone Is PPARγ Mediated and Involves Modification of Nuclear NF-κB p65/p50 Ratio. Int J Mol Sci, 22(21).
8. Jiang C., Zhang C., Dai M., et al. (2024). Interplay between SUMO1-related SUMOylation and phosphorylation of p65 promotes hepatocellular carcinoma progression. Biochim Biophys Acta Mol Cell Res, 1871(1): 119595